FDA — authorised 27 April 1955
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
🇺🇸 Solu-Cortef in United States
FDA authorised Solu-Cortef on 27 April 1955
Marketing authorisation
Solu-Cortef in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Solu-Cortef approved in United States?
Yes. FDA authorised it on 27 April 1955.
Who is the marketing authorisation holder for Solu-Cortef in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.